Concepts (148)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Smad4 Protein | 2 | 2019 | 163 | 0.800 |
Why?
|
Vasculitis | 1 | 2023 | 519 | 0.660 |
Why?
|
Rheumatic Diseases | 1 | 2023 | 592 | 0.560 |
Why?
|
Colectomy | 2 | 2018 | 683 | 0.540 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2018 | 365 | 0.510 |
Why?
|
Acetaminophen | 1 | 2018 | 545 | 0.480 |
Why?
|
Insurance Claim Review | 1 | 2018 | 720 | 0.460 |
Why?
|
General Surgery | 2 | 2020 | 1636 | 0.410 |
Why?
|
Autoimmune Diseases | 1 | 2023 | 2133 | 0.390 |
Why?
|
Perioperative Care | 1 | 2018 | 1002 | 0.370 |
Why?
|
Rectal Neoplasms | 4 | 2021 | 1206 | 0.370 |
Why?
|
Rectum | 2 | 2021 | 904 | 0.260 |
Why?
|
Pediatrics | 1 | 2020 | 3475 | 0.260 |
Why?
|
Colorectal Neoplasms | 3 | 2019 | 6773 | 0.250 |
Why?
|
Oropharyngeal Neoplasms | 2 | 2021 | 477 | 0.240 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5319 | 0.210 |
Why?
|
Analgesics, Opioid | 1 | 2018 | 3674 | 0.210 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2021 | 9239 | 0.200 |
Why?
|
Pharynx | 1 | 2023 | 413 | 0.180 |
Why?
|
Papillomavirus Infections | 2 | 2022 | 1587 | 0.180 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2019 | 2948 | 0.170 |
Why?
|
Defecation | 1 | 2020 | 188 | 0.170 |
Why?
|
Vocal Cord Paralysis | 1 | 2022 | 267 | 0.160 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11524 | 0.160 |
Why?
|
Alphapapillomavirus | 1 | 2021 | 221 | 0.150 |
Why?
|
Surgery, Oral | 1 | 2020 | 146 | 0.150 |
Why?
|
Fluorouracil | 2 | 2019 | 1619 | 0.150 |
Why?
|
Tonsillectomy | 1 | 2020 | 255 | 0.150 |
Why?
|
Otorhinolaryngologic Diseases | 1 | 2017 | 90 | 0.150 |
Why?
|
GTP Phosphohydrolases | 1 | 2019 | 509 | 0.140 |
Why?
|
Watchful Waiting | 1 | 2020 | 492 | 0.140 |
Why?
|
Injections, Intravenous | 1 | 2018 | 1420 | 0.130 |
Why?
|
Ecosystem | 1 | 2020 | 474 | 0.130 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2019 | 1692 | 0.130 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2020 | 454 | 0.130 |
Why?
|
Liver Neoplasms | 3 | 2019 | 4253 | 0.130 |
Why?
|
Respiratory Tract Infections | 1 | 2022 | 961 | 0.120 |
Why?
|
Universities | 1 | 2020 | 956 | 0.120 |
Why?
|
Organoids | 1 | 2019 | 701 | 0.110 |
Why?
|
World Health Organization | 1 | 2019 | 1318 | 0.110 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2018 | 1038 | 0.110 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2019 | 2043 | 0.110 |
Why?
|
Drug Utilization | 1 | 2018 | 1183 | 0.100 |
Why?
|
Disease-Free Survival | 2 | 2021 | 6895 | 0.100 |
Why?
|
Neoadjuvant Therapy | 2 | 2020 | 2728 | 0.100 |
Why?
|
Ambulatory Care Facilities | 1 | 2017 | 933 | 0.100 |
Why?
|
Antibiotic Prophylaxis | 1 | 2016 | 639 | 0.100 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2018 | 3557 | 0.090 |
Why?
|
Colon | 1 | 2018 | 1772 | 0.090 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2018 | 3479 | 0.090 |
Why?
|
Cost of Illness | 1 | 2020 | 1859 | 0.090 |
Why?
|
Retrospective Studies | 12 | 2022 | 77449 | 0.090 |
Why?
|
Radiation Injuries | 1 | 2016 | 1180 | 0.090 |
Why?
|
Thyroid Neoplasms | 1 | 2022 | 2282 | 0.080 |
Why?
|
Pain, Postoperative | 1 | 2018 | 1643 | 0.080 |
Why?
|
Sequence Analysis, DNA | 1 | 2019 | 4803 | 0.080 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5391 | 0.080 |
Why?
|
Humans | 24 | 2023 | 744343 | 0.070 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2020 | 1813 | 0.070 |
Why?
|
Surgical Wound Infection | 1 | 2016 | 1540 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3647 | 0.070 |
Why?
|
Colonic Neoplasms | 1 | 2018 | 2541 | 0.070 |
Why?
|
Antineoplastic Agents | 2 | 2020 | 13695 | 0.070 |
Why?
|
Databases, Factual | 2 | 2018 | 7729 | 0.070 |
Why?
|
Head and Neck Neoplasms | 1 | 2020 | 2734 | 0.070 |
Why?
|
Glioblastoma | 1 | 2020 | 3481 | 0.060 |
Why?
|
Referral and Consultation | 1 | 2017 | 3528 | 0.060 |
Why?
|
Prognosis | 3 | 2019 | 29063 | 0.060 |
Why?
|
Quality of Life | 2 | 2023 | 12804 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2018 | 5172 | 0.060 |
Why?
|
Middle Aged | 9 | 2020 | 213383 | 0.060 |
Why?
|
Aged | 7 | 2020 | 163280 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2019 | 7880 | 0.050 |
Why?
|
Neoplasm Staging | 3 | 2021 | 11031 | 0.050 |
Why?
|
Male | 11 | 2020 | 350118 | 0.050 |
Why?
|
Cohort Studies | 3 | 2019 | 40561 | 0.050 |
Why?
|
Female | 11 | 2020 | 380194 | 0.050 |
Why?
|
Child, Preschool | 2 | 2020 | 41006 | 0.050 |
Why?
|
Recurrent Laryngeal Nerve | 1 | 2022 | 139 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39050 | 0.050 |
Why?
|
Infant, Newborn | 1 | 2020 | 25625 | 0.040 |
Why?
|
Neck Dissection | 1 | 2021 | 197 | 0.040 |
Why?
|
Infusions, Intra-Arterial | 1 | 2019 | 234 | 0.040 |
Why?
|
Inhibitory Concentration 50 | 1 | 2020 | 459 | 0.040 |
Why?
|
Neoplasm Metastasis | 2 | 2019 | 4851 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2020 | 8863 | 0.040 |
Why?
|
Iodine Radioisotopes | 1 | 2022 | 1032 | 0.040 |
Why?
|
Infant | 1 | 2020 | 35136 | 0.040 |
Why?
|
Emergency Service, Hospital | 1 | 2017 | 7659 | 0.040 |
Why?
|
Mutation | 2 | 2019 | 29786 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 7181 | 0.040 |
Why?
|
Adult | 7 | 2021 | 214055 | 0.040 |
Why?
|
Organ Preservation | 1 | 2020 | 331 | 0.040 |
Why?
|
Natural Orifice Endoscopic Surgery | 1 | 2019 | 118 | 0.040 |
Why?
|
Adolescent | 3 | 2020 | 85781 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2019 | 63114 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2016 | 15519 | 0.040 |
Why?
|
Organs at Risk | 1 | 2019 | 346 | 0.040 |
Why?
|
Thyroidectomy | 1 | 2022 | 879 | 0.030 |
Why?
|
Microsatellite Repeats | 1 | 2018 | 802 | 0.030 |
Why?
|
Hospitals, Urban | 1 | 2017 | 499 | 0.030 |
Why?
|
DNA Mismatch Repair | 1 | 2018 | 426 | 0.030 |
Why?
|
Child | 2 | 2020 | 77709 | 0.030 |
Why?
|
Lymph Node Excision | 1 | 2021 | 1261 | 0.030 |
Why?
|
Mice | 2 | 2019 | 81183 | 0.030 |
Why?
|
Postoperative Period | 1 | 2020 | 1842 | 0.030 |
Why?
|
Papillomaviridae | 1 | 2021 | 1119 | 0.030 |
Why?
|
New York | 1 | 2016 | 886 | 0.030 |
Why?
|
Prospective Studies | 1 | 2018 | 53288 | 0.030 |
Why?
|
Goals | 1 | 2019 | 706 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2018 | 1880 | 0.030 |
Why?
|
India | 1 | 2020 | 2197 | 0.030 |
Why?
|
Polysomnography | 1 | 2020 | 1776 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2021 | 2924 | 0.030 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2016 | 644 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15540 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2020 | 57776 | 0.030 |
Why?
|
Monitoring, Physiologic | 1 | 2020 | 1738 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2022 | 2942 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2018 | 1821 | 0.020 |
Why?
|
Genetic Markers | 1 | 2016 | 2634 | 0.020 |
Why?
|
Animals | 2 | 2019 | 168757 | 0.020 |
Why?
|
Prevalence | 2 | 2016 | 15226 | 0.020 |
Why?
|
Gastrointestinal Diseases | 1 | 2016 | 1170 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2016 | 4933 | 0.020 |
Why?
|
Anesthesia | 1 | 2019 | 1561 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3952 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3597 | 0.020 |
Why?
|
Survival Analysis | 1 | 2019 | 10252 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2018 | 3586 | 0.020 |
Why?
|
Acute Disease | 1 | 2016 | 7149 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12788 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2018 | 2988 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11366 | 0.020 |
Why?
|
Risk | 1 | 2016 | 9687 | 0.010 |
Why?
|
Lung | 1 | 2022 | 9856 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2020 | 16689 | 0.010 |
Why?
|
Quality Improvement | 1 | 2017 | 3749 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 21746 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10262 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 20947 | 0.010 |
Why?
|
Risk Factors | 2 | 2020 | 72290 | 0.010 |
Why?
|
Logistic Models | 1 | 2016 | 13408 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 40075 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 25043 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2019 | 13102 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 17446 | 0.010 |
Why?
|
Young Adult | 1 | 2016 | 56430 | 0.010 |
Why?
|
Concepts
(148)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(27)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_